Patents by Inventor Jonathan A. BOHMANN

Jonathan A. BOHMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963959
    Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: April 23, 2024
    Assignees: Southwest Research Institute, The Government of the United States, as represented by The Secretary of the Army, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Jonathan A. Bohmann, Nadean M. Gutierrez, Joseph A. Mcdonough, Robert Francis Campbell, Michael Gordon Joyce, Rekha Panchal, Rajeshwer Sankhala, Allen Duplantier
  • Patent number: 11865111
    Abstract: Antiviral drugs targeting the N-terminal domain (NTD) of the spike receptor binding domain (RBD) and methods of treating a subject suffering from coronavirus.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: January 9, 2024
    Assignees: Southwest Research Institute, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Government of the United States, as Represented by the Secretary of the Army
    Inventors: Jonathan A. Bohmann, Nadean M. Gutierrez, Joseph A. McDonough, Robert Francis Campbell, Michael Gordon Joyce, Rekha Panchal, Rajeshwer Sankhala, Allen Duplantier
  • Publication number: 20230074535
    Abstract: Antiviral drugs targeting the N-terminal domain (NTD) of the spike receptor binding domain (RBD) and methods of treating a subject suffering from coronavirus.
    Type: Application
    Filed: August 11, 2022
    Publication date: March 9, 2023
    Inventors: Jonathan A. BOHMANN, Nadean M. GUTIERREZ, Joseph A. MCDONOUGH, Robert Francis CAMPBELL, Michael Gordon JOYCE, Rekha PANCHAL, Rajeshwer SANKHALA, Allen DUPLANTIER
  • Publication number: 20230065024
    Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 2, 2023
    Inventors: Jonathan A. BOHMANN, Nadean M. GUTIERREZ, Joseph A. MCDONOUGH, Robert Francis CAMPBELL, Michael Gordon JOYCE, Rekha PANCHAL, Rajeshwer SANKHALA, Allen DUPLANTIER
  • Publication number: 20220047528
    Abstract: Methods of inhibiting LSD1 activity by administering a compound that binds to SWIRM domain of LSD1 and inhibits LSD1 activity; methods of inhibiting LSD1 activity where the compound interacts with L547 residue within the hydrophobic pocket of LSD1; methods of determining the efficacy of a drug to be an LSD1 inhibitor wherein a candidate drug is screened to determine whether it binds to SWIRM domain of LSD1 and inhibits LSD1 activity.
    Type: Application
    Filed: July 26, 2021
    Publication date: February 17, 2022
    Inventors: Shawn Blumberg, Jonathan Bohmann, Aundrietta D. Duncan, Stephen Horrigan, Bruce McCreedy, Daniela Santiesteban
  • Publication number: 20190275027
    Abstract: Bis-benzyl-tetrahydroisoquinoline analogs that are derivatives of the cyclic products tetrandrine (TETN) and cepharanthine (CEPH). The analogs indicate activity against filovirus infections, including the type species Marburg virus (MARV) and Ebola virus (EBOV).
    Type: Application
    Filed: March 9, 2018
    Publication date: September 12, 2019
    Inventors: William E. BAUTA, Jonathan A. BOHMANN, Michael W. TIDWELL, Andrey D. MALAKHOV, Alejandro SANTILLAN, JR.